Funds · 13F filer · Tel Aviv, L3

Sphera Funds Management Ltd.

$698.8M in 97 U.S. stocks and ETFs at the end of June 30, 2026, as reported to the SEC.1

1y return+103.3%S&P 500 +20.9%
3y return+95.5%S&P 500 +68.5%
5y return+75.8%S&P 500 +74.5%
10y return+233.4%S&P 500 +256.5%

These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.

$100 invested in its stock picks

Since June 30, 2016: $333 against $357 in the S&P 500.2

Sphera Funds Management Ltd.S&P 500 (SPY)
$100$35720162026

Top holdings

At the end of June 30, 2026. Change is in shares since the quarter before.2

StockValueShare of portfolioChange
Teva Pharmaceutical Inds LtdCUSIP 881624209$50.8M7.3%+31.9%
MLYSMineralys Therapeutics Inc$39.7M5.7%+9.7%
Tower Semiconductor LtdCUSIP M87915274$28.2M4.0%−25.7%
SNDXSyndax Pharmaceuticals Inc$22.2M3.2%+40.0%
BIIBBiogen Inc$20.9M3.0%+4.4%
RAREUltragenyx Pharmaceutical In$19.6M2.8%−27.3%
BMRNBiomarin Pharmaceutical Inc$18.8M2.7%+134.8%
CYTKCytokinetics Inc$18.7M2.7%+452.5%
BBIOBridgebio Pharma Inc$18.3M2.6%
COGTCogent Biosciences Inc$17.8M2.5%+10.3%
Nova LtdCUSIP M7516K103$13.7M2.0%−52.8%
INSMInsmed Inc$12.7M1.8%New
MAZEMaze Therapeutics Inc$12.5M1.8%+83.7%
Astrazeneca PLCCUSIP G0593M107$11.9M1.7%
SNYSanofi Sa$11.5M1.6%
Cybin IncCUSIP 23256X407$10.7M1.5%+64.2%
LLYEli Lilly & Co$9.6M1.4%−11.1%
MDGLMadrigal Pharmaceuticals Inc$9.4M1.3%+92.7%
TRVITrevi Therapeutics Inc$9.3M1.3%−13.1%
ACADAcadia Pharmaceuticals Inc$9.0M1.3%+39.2%
CLDXCelldex Therapeutics Inc New$9.0M1.3%−1.1%
RYTMRhythm Pharmaceuticals Inc$8.9M1.3%New
ORICOric Pharmaceuticals Inc$8.2M1.2%+40.1%
LRCXLam Research Corp$8.0M1.1%New
AMATApplied Matls Inc$8.0M1.1%New

Best picks still held

How each current holding has done since the quarter it first appeared in its filings (up to six years back).

StockHeld sinceReturn sinceNow worth
LLYEli Lilly & CoJune 30, 2020+630.6%$9.6M
Tower Semiconductor LtdCUSIP M87915274June 30, 2023+594.7%$28.2M
COGTCogent Biosciences IncMarch 31, 2025+546.1%$17.8M
BBIOBridgebio Pharma IncMarch 31, 2023+349.2%$18.3M
Teva Pharmaceutical Inds LtdCUSIP 881624209March 31, 2023+282.8%$50.8M
TNGXTango Therapeutics IncDecember 31, 2025+252.8%$7.9M
TRVITrevi Therapeutics IncJune 30, 2025+241.0%$9.3M
CYTKCytokinetics IncSeptember 30, 2023+189.2%$18.7M
MAZEMaze Therapeutics IncMarch 31, 2025+171.0%$12.5M
Nova LtdCUSIP M7516K103September 30, 2024+160.6%$13.7M

Sold off last quarter

  • Amicus TherapeuticCUSIP 03152W109 was $8.7M
  • Cellebrite Di LtdCUSIP M2197Q107 was $8.7M
  • Apellis Pharmaceuticals IncCUSIP 03753U106 was $8.6M
  • PANWPalo Alto Networks Inc was $8.5M
  • Camtek LtdCUSIP M20791105 was $8.0M
  • Soleno Therapeutics IncCUSIP 834203309 was $7.2M
  • AMZNAmazon Com Inc was $6.7M
  • AAOIApplied Optoelectronics Inc was $6.2M
  • ENPHEnphase Energy Inc was $5.4M
  • Zim Integrated Shipping ServCUSIP M9T951109 was $2.8M

Quarter by quarter

QuarterIts picksS&P 500
June 30, 2026+16.2%+14.8%
March 31, 2026+10.2%−4.6%
December 31, 2025+23.3%+2.4%
September 30, 2025+28.8%+7.8%
June 30, 2025+7.4%+10.5%
March 31, 2025−13.8%−4.6%
December 31, 2024−7.1%+2.1%
September 30, 2024−0.1%+5.4%
June 30, 2024−8.0%+4.0%
March 31, 2024+15.3%+10.0%
December 31, 2023+16.2%+11.2%
September 30, 2023−9.2%−3.6%
June 30, 2023+6.8%+8.3%
March 31, 2023−4.3%+7.0%
December 31, 2022+12.2%+7.1%
September 30, 2022−1.4%−5.3%
June 30, 2022−9.5%−16.5%
March 31, 2022−8.9%−4.9%
December 31, 2021+2.0%+10.7%
September 30, 2021−5.4%+0.3%

Sources

Every number on this page points here. Each one links to the public record.

  1. 1
    CIK 1496201
  2. 2
    Filed August 14, 2026 · accession 0001496201-26-000004